The European Union has yet to place new orders for AstraZeneca (AZN.L) vaccines beyond June, when their contract ends, European Internal Market Commissioner Thierry Breton said on Sunday.
Breton also said he expected the costs of the recent EU order for more doses of Pfizer-BioNTech (PFE.N) vaccine to be higher than previous versions.
Last month, the Commission launched legal action against AstraZeneca for breaching its contract to supply COVID-19 vaccines and for not having a ‘reliable’ plan to ensure timely deliveries. Read more
“We did not renew the order after June. We’ll see what happens, ”Breton said, adding that it was“ a very good vaccine ”.
Concerns have increased about the potential side effects of the Anglo-Swedish COVID-19 vaccine.
The European medicines regulator said on Friday it was examining reports of a rare neurodegenerative disorder in people who received the injections, a move that comes after finding out that the vaccine may have caused very rare cases of clotting. blood. Read more
Breton said an increase in prices for second-generation vaccines may be justified by the additional research required and potential changes in industrial equipment.
The European Union has signed a new contract with Pfizer-Biontech to receive 1.8 billion doses of COVID-19 vaccines for 2021-2023, to cover recalls, donations and resale of doses, the European Commission announced on Friday. . Read more
“There may be a small additional cost but I will let the competent authorities unveil it in due time,” he told France Inter radio.
Our Standards: The Thomson Reuters Trust Principles.